Literature DB >> 19776089

Topical chemotherapy for ocular surface squamous neoplasia: current status.

Ricardo Sepulveda1, Jacob Pe'er, Edoardo Midena, Stefan Seregard, Harminder S Dua, Arun D Singh.   

Abstract

Although there are no randomised trials directly comparing topical chemotherapeutic agents mitomycin-C, 5-fluorouracil, and interferon-alpha2b, published studies indicate equal efficacy of these agents for treatment of non-invasive ocular surface squamous neoplasia (80%-88%). 5-Fluorouracil may be preferred, given low incidence of serious side effects and low cost to the patient.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19776089     DOI: 10.1136/bjo.2009.160820

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  16 in total

1.  Surgical versus Medical Treatment of Ocular Surface Squamous Neoplasia: A Cost Comparison.

Authors:  Christina S Moon; Afshan A Nanji; Anat Galor; Kathryn E McCollister; Carol L Karp
Journal:  Ophthalmology       Date:  2015-12-11       Impact factor: 12.079

2.  Topical Bevacizumab for the Treatment of Ocular Surface Squamous Neoplasia.

Authors:  Leyla Asena; Dilek Dursun Altınörs
Journal:  J Ocul Pharmacol Ther       Date:  2015-06-26       Impact factor: 2.671

3.  Update on the Management of Ocular Surface Squamous Neoplasia.

Authors:  Umangi Patel; Carol L Karp; Sander R Dubovy
Journal:  Curr Ophthalmol Rep       Date:  2021-02-20

Review 4.  Ultra high-resolution anterior segment optical coherence tomography in the diagnosis and management of ocular surface squamous neoplasia.

Authors:  Benjamin J Thomas; Anat Galor; Afshan A Nanji; Fouad El Sayyad; Jianhua Wang; Sander R Dubovy; Madhura G Joag; Carol L Karp
Journal:  Ocul Surf       Date:  2013-11-09       Impact factor: 5.033

5.  Widespread Ocular Surface Squamous Neoplasia Treated with Topical Interferon Alpha-2b.

Authors:  Hershel Patel; Lauren J Jeang; Ankit Shah; Edgar M Espana; Curtis E Margo
Journal:  Ocul Oncol Pathol       Date:  2018-02-13

Review 6.  Tumors of the ocular surface: A review.

Authors:  Santosh G Honavar; Fairooz P Manjandavida
Journal:  Indian J Ophthalmol       Date:  2015-03       Impact factor: 1.848

7.  Clinical outcome of advanced squamous cell carcinoma of the conjunctiva.

Authors:  C V Miller; A Wolf; A Klingenstein; C Decker; A Garip; A Kampik; C Hintschich
Journal:  Eye (Lond)       Date:  2014-05-23       Impact factor: 3.775

8.  Recombinant interferon alpha 2b for ocular surface squamous neoplasia: An efficient and cost-effective treatment modality in Asian Indian patients.

Authors:  Swathi Kaliki; Swati Singh; Sadiya Iram; Dharani Tripuraneni
Journal:  Indian J Ophthalmol       Date:  2016-10       Impact factor: 1.848

9.  Topical chemotherapy for giant ocular surface squamous neoplasia of the conjunctiva and cornea: Is surgery necessary?

Authors:  Sonal S Chaugule; Jennifer Park; Paul T Finger
Journal:  Indian J Ophthalmol       Date:  2018-01       Impact factor: 1.848

10.  Factors related to survival outcomes following orbital exenteration: a retrospective, comparative, case series.

Authors:  Orapan Aryasit; Passorn Preechawai; Chakree Hirunpat; Orasa Horatanaruang; Penny Singha
Journal:  BMC Ophthalmol       Date:  2018-07-28       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.